Viewing Study NCT04035434

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-06-26 @ 4:29 AM
Study NCT ID: NCT04035434
Status: TERMINATED
Last Update Posted: 2025-10-24
First Post: 2019-07-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)
Sponsor: CRISPR Therapeutics AG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Malignancy View
None Non-Hodgkin Lymphoma View
None B-cell Lymphoma View
None Adult B Cell ALL View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR T View
None Non-Hodgkin Lymphoma View
None NHL View
None Lymphoma View
None Allogeneic View
None Leukemia View